Journal of
AIDS and HIV Research

  • Abbreviation: J. AIDS HIV Res.
  • Language: English
  • ISSN: 2141-2359
  • DOI: 10.5897/JAHR
  • Start Year: 2009
  • Published Articles: 302

Full Length Research Paper

CD4 T-Lymphocytes, adherence and sociodemographic factors associated with viral load outcome of people living with HIV (PLHIV) on antiretroviral therapy in Lagos State, Nigeria

Oluwatosin Temitope Ogungbade
  • Oluwatosin Temitope Ogungbade
  • West Africa Centre for Public Health and Development (WACPHD), an affiliate of the Institute of Global Public Health, University of Manitoba, Winnipe Canada.
  • Google Scholar
Clifford Umeh
  • Clifford Umeh
  • Heartland Alliance Limited by Guarantee (HALG), Abuja, Nigeria.
  • Google Scholar
Omololuoye Majekodunmi
  • Omololuoye Majekodunmi
  • Heartland Alliance Limited by Guarantee (HALG), Abuja, Nigeria.
  • Google Scholar
Ogonnaya Kanu-Oji
  • Ogonnaya Kanu-Oji
  • Heartland Alliance Limited by Guarantee (HALG), Abuja, Nigeria.
  • Google Scholar
John Paul Mbah
  • John Paul Mbah
  • Heartland Alliance Limited by Guarantee (HALG), Abuja, Nigeria.
  • Google Scholar
Bartholomew Ochonye
  • Bartholomew Ochonye
  • Heartland Alliance Limited by Guarantee (HALG), Abuja, Nigeria.
  • Google Scholar
Kalada Green
  • Kalada Green
  • West Africa Centre for Public Health and Development (WACPHD), an affiliate of the Institute of Global Public Health, University of Manitoba, Winnipe Canada.
  • Google Scholar
Elijah Mmokutmfon
  • Elijah Mmokutmfon
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Obinna Chigbundu
  • Obinna Chigbundu
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Onyeka Igboelina
  • Onyeka Igboelina
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Dolapo Ogundehin
  • Dolapo Ogundehin
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Gbenga Asaolu
  • Gbenga Asaolu
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Chika Obiora-Okafo
  • Chika Obiora-Okafo
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Augustine Idemudia
  • Augustine Idemudia
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Chukwuka Nwadike
  • Chukwuka Nwadike
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Babatunde Oyawola
  • Babatunde Oyawola
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Bayo Onimode
  • Bayo Onimode
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Betty Pius
  • Betty Pius
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Kunle Kakanfo
  • Kunle Kakanfo
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Pamela Gado
  • Pamela Gado
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Moses Katbi
  • Moses Katbi
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
David Onime
  • David Onime
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Ezekiel James
  • Ezekiel James
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Jameh Pius
  • Jameh Pius
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Omosalewa Oyelaran
  • Omosalewa Oyelaran
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Adebobola Bashorun
  • Adebobola Bashorun
  • National AIDS, Sexually Transmitted Infections Control and Hepatitis Programme (NASCP), Federal Ministry of Health, Abuja, Nigeria.
  • Google Scholar
Temitope Ilori
  • Temitope Ilori
  • National Agency for the Control of AIDS (NACA), Abuja, Nigeria.
  • Google Scholar
Kingston Omo-Emmanuel
  • Kingston Omo-Emmanuel
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Okpanachi Momoh
  • Okpanachi Momoh
  • Heartland Alliance Limited by Guarantee (HALG), Abuja, Nigeria.
  • Google Scholar
Chukwuebuka Ejeckam
  • Chukwuebuka Ejeckam
  • West Africa Centre for Public Health and Development (WACPHD), an affiliate of the Institute of Global Public Health, University of Manitoba, Winnipe Canada.
  • Google Scholar


  •  Received: 28 August 2024
  •  Accepted: 25 October 2024
  •  Published: 31 March 2025

Abstract

Globally, a significant number of people were living with HIV in 2022, with a substantial proportion receiving antiretroviral therapy (ART). Despite these advancements, HIV continues to pose a serious challenge to global health. Against this backdrop, this study evaluated CD4 T-lymphocytes, adherence, and sociodemographic factors associated with the current viral load outcome of People Living with HIV (PLHIV) on ART in Lagos State, Nigeria, supported by the USAID-funded project - Accelerating the control of HIV Epidemic in Nigeria, Cluster 6 (ACE-6). The study utilized a retrospective design to study 19,183 registered people living with HIV (PLHIV) receiving ART on the ACE 6 project in Lagos, Nigeria. The end-line data of the PLHIV formed the basis of the analysis using Binary Logistic Regression at a 5% significance level. The analysis was facilitated using SPSS version 23 software. The results showed an average age of 41.28±20.07 while there was no significant association between multimonth dispensing (MMD) duration and viral load outcome among the patients (χ2 = 7.583, df = 5, p = 0.181). Socio-demographic factors like Apapa residence (OR: 1.511), Surulere (OR: 1.461), and Kosofe (OR: 1.573) were significantly associated with the last viral load suppression (VLS) Outcome. Primary level education (UOR: 0.000) and being employed (OR: 0.804) predicted (VLS). However, gender was not significantly associated with VLS. Patients who poorly adhered to ART (OR: 0.852) were significantly less likely to achieve viral suppression than those with good adherence. However, CD4 cell counts were not an independent predictor of viral load suppression. The study concludes that poor adherence to ART significantly reduces the likelihood of viral suppression among people living with HIV (PLHIV). At the same time, CD4 cell counts are not independent predictors of viral load suppression. Therefore, it is recommended to enhance adherence strategies to improve viral suppression outcomes among registered hospital-based HIV patients. Additionally, targeted interventions should consider socio-demographic factors such as residence and employment outcomes to further support viral load suppression efforts.

Key words: Viral load suppression, antiretroviral therapy (ART) adherence, CD4 cell counts.